Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,914 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675.
Dronca RS, Allred JB, Perez DG, Nevala WK, Lieser EA, Thompson M, Maples WJ, Creagan ET, Pockaj BA, Kaur JS, Moore TD, Marchello BT, Markovic SN. Dronca RS, et al. Among authors: thompson m. Am J Clin Oncol. 2014 Aug;37(4):369-76. doi: 10.1097/COC.0b013e31827b45d4. Am J Clin Oncol. 2014. PMID: 23357973 Free PMC article. Clinical Trial.
Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma.
Nevala WK, Vachon CM, Leontovich AA, Scott CG, Thompson MA, Markovic SN; Melanoma Study Group of the Mayo Clinic Cancer Center. Nevala WK, et al. Among authors: thompson ma. Clin Cancer Res. 2009 Mar 15;15(6):1931-9. doi: 10.1158/1078-0432.CCR-08-1980. Epub 2009 Feb 24. Clin Cancer Res. 2009. PMID: 19240164 Free PMC article.
Fluctuation of systemic immunity in melanoma and implications for timing of therapy.
Leontovich AA, Dronca RS, Suman VJ, Ashdown ML, Nevala WK, Thompson MA, Robinson A, Kottschade LA, Kaur JS, McWilliams RR, Ivanov LV, Croghan GA, Markovic SN. Leontovich AA, et al. Front Biosci (Elite Ed). 2012 Jan 1;4(3):958-75. doi: 10.2741/E433. Front Biosci (Elite Ed). 2012. PMID: 22201928 Free article.
Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma.
Galanis E, Markovic SN, Suman VJ, Nuovo GJ, Vile RG, Kottke TJ, Nevala WK, Thompson MA, Lewis JE, Rumilla KM, Roulstone V, Harrington K, Linette GP, Maples WJ, Coffey M, Zwiebel J, Kendra K. Galanis E, et al. Among authors: thompson ma. Mol Ther. 2012 Oct;20(10):1998-2003. doi: 10.1038/mt.2012.146. Epub 2012 Aug 7. Mol Ther. 2012. PMID: 22871663 Free PMC article. Clinical Trial.
T cell Bim levels reflect responses to anti-PD-1 cancer therapy.
Dronca RS, Liu X, Harrington SM, Chen L, Cao S, Kottschade LA, McWilliams RR, Block MS, Nevala WK, Thompson MA, Mansfield AS, Park SS, Markovic SN, Dong H. Dronca RS, et al. Among authors: thompson ma. JCI Insight. 2016 May 5;1(6):e86014. doi: 10.1172/jci.insight.86014. JCI Insight. 2016. PMID: 27182556 Free PMC article.
Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAF V600E -mutant melanoma.
Harris AL, Lee SE, Dawson LK, Marlow LA, Edenfield BH, Durham WF, Flotte TJ, Thompson M, Small DL, Synnott AJ, Markovic SN, Copland JA. Harris AL, et al. Among authors: thompson m. Oncotarget. 2017 Dec 23;9(13):10905-10919. doi: 10.18632/oncotarget.23649. eCollection 2018 Feb 16. Oncotarget. 2017. PMID: 29541385 Free PMC article.
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment.
Weber JS, Levit LA, Adamson PC, Bruinooge SS, Burris HA 3rd, Carducci MA, Dicker AP, Gönen M, Keefe SM, Postow MA, Thompson MA, Waterhouse DM, Weiner SL, Schuchter LM. Weber JS, et al. Among authors: thompson ma. J Clin Oncol. 2017 Jan 10;35(2):139-140. doi: 10.1200/JCO.2016.70.4692. Epub 2016 Nov 28. J Clin Oncol. 2017. PMID: 27893329 Free PMC article. No abstract available.
6,914 results